IDH1 and central nervous system cancer: The analysis reveals that a higher expression of miR-181a is significantly associated with younger age of patients (<54-year, p = 0.006), lower tumor malignancy grade (p = 0.036), and gliomas with a mutant-type of IDH1 (p = 0.002) (see Table 1; Figure 2a–c).